Langer Jerome A, Cutrone E Cali, Kotenko Sergei
Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 675 Hoes Lane, Piscataway, NJ 08854, USA.
Cytokine Growth Factor Rev. 2004 Feb;15(1):33-48. doi: 10.1016/j.cytogfr.2003.10.001.
Expanded genomic information has driven the discovery of new members of the human Class II family of cytokine receptors (CRF2), which now includes 12 proteins. The corresponding cytokines have been identified, paired with their receptors and initially characterized for function. These cytokines include: a new human Type I IFN, IFN-kappa; molecules related to IL-10 (IL-19, IL-20, IL-22, IL-24, IL-26); and IFN-lambdas (IL-28/29), which have antiviral and cell stimulatory activities reminiscent of Type I IFNs, but act through a distinct receptor. In response to ligand binding, the CRF2 proteins form heterodimers, leading to cytokine-specific cellular responses; these diverse physiological functions are just beginning to be explored. Progress in structural and mutational analysis of ligand-receptor interactions now presents a more reliable framework for understanding receptor-ligand interactions, and for predicting key regions in less well studied members of the CRF2 family. The relationships between the CRF2 proteins will be summarized, as will the progress in identifying patterns of receptor interactions with ligands.
扩展的基因组信息推动了人类细胞因子受体II类家族(CRF2)新成员的发现,该家族目前包括12种蛋白质。相应的细胞因子已被鉴定出来,与它们的受体配对,并初步进行了功能表征。这些细胞因子包括:一种新的人类I型干扰素,即干扰素κ;与IL-10相关的分子(IL-19、IL-20、IL-22、IL-24、IL-26);以及干扰素λ(IL-28/29),它们具有类似于I型干扰素的抗病毒和细胞刺激活性,但通过不同的受体发挥作用。响应配体结合时,CRF2蛋白形成异二聚体,导致细胞因子特异性的细胞反应;这些多样的生理功能才刚刚开始被探索。配体-受体相互作用的结构和突变分析进展为理解受体-配体相互作用以及预测CRF2家族中研究较少成员的关键区域提供了更可靠的框架。将总结CRF2蛋白之间的关系,以及在确定受体与配体相互作用模式方面的进展。